Significance of dipyridamole loading in ultrafast x-ray computed tomography for detection of myocardial ischemia. A study in patients with Kawasaki disease.
To examine the significance of dipyridamole loading as a stress in ultrafast computed tomography (CT) to improve the detection of left ventricular myocardial ischemia. Thirty-eight patients with coronary arterial involvement of Kawasaki disease and 18 control subjects received cardiac ultrafast CT with intravenous long-bolus iodinated contrast injection; dipyridamole was loaded in 40 examinations. Early (first-pass) and late (4 minutes) M/Ls (ratio of postcontrast incremental increases in the left ventricular myocardial [M] and luminal [L] CT number) were analyzed. Dipyridamole induced a prominent increase in early M/L of the normal myocardium in control subjects (no loading: 26.8%, dipyridamole: 39.2%; P < 0.001) with small influence on late M/Ls. In ischemic or infarcted myocardium in Kawasaki disease, dipyridamole early M/Ls (20.4%, 16.0%) and late M/Ls showed no difference from corresponding values without loading. Using early M/L with dipyridamole, sensitivity and specificity for detection of ischemic abnormalities were 89% and 100%, respectively. Dipyridamole-loaded first-pass contrast ultrafast CT was proven to have excellent detectability for myocardial ischemia comparable with stress thallium scintigraphy.